Anhui Huaheng Biotechnology Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 579.98 million compared to CNY 349.97 million a year ago. Revenue was CNY 628.91 million compared to CNY 379.64 million a year ago.

Net income was CNY 128.99 million compared to CNY 62.13 million a year ago. Basic earnings per share from continuing operations was CNY 0.8207 compared to CNY 0.4759 a year ago. Diluted earnings per share from continuing operations was CNY 0.8207 compared to CNY 0.4759 a year ago.